LTA4H and inflammatory bowel disease: Evidently, imidazopyridines were reported as potent inhibitors for leukotriene A4 hydrolase, a pro-inflammatory mediator implicated in the pathogenesis of a number of diseases including inflammatory bowel disease and arthritis [32].Therefore, we considered the Phospholipase A2 as a predictive target for the novel imidazopyridines.